Tuberculosis News and Research

Latest Tuberculosis News and Research

Disease diagnostic tools win top honors in DEBUT challenge

Tools to diagnose Alzheimer's disease and latent tuberculosis are among the winning projects in the Design by Biomedical Undergraduate Teams (DEBUT) challenge, a biomedical engineering design prize competition for teams of undergraduate students.

26 Aug 2017

Living near newly built roads in Ethiopia linked to higher rates of infant mortality

Researchers have shown that living near newly built roads in Ethiopia is associated with higher rates of infant mortality. Proximity to new roads has negative health effects because of toxic waste dumped illegally during the construction phase, according to early research by economists at Queen Mary University of London and Trinity College Dublin.

24 Aug 2017

Understanding the rise in NTM infections

It is important to keep in mind that nontuberculous mycobacteria are environmental, and so unlike mycobacterial tuberculosis, generally this is not a person to person transmitted disease. The organisms are found universally in water and soil and so most people are exposed on a daily basis.

16 Aug 2017

South Texas fights tuberculosis one blood test at a time

Like most people at Haven for Hope, San Antonio’s largest homeless shelter, James Harrison doesn’t plan on staying long. “I lost my apartment and had nowhere else to go,” he explained.

8 Aug 2017

New way of screening compounds may help speed up drug development

Scientists have created a new way of screening compounds that is more sensitive than existing methods, opening up the possibility of finding new drugs for many diseases.

7 Aug 2017

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

Novel molecular tests are gaining popularity as a rapid way to detect genetic mutations that render tuberculosis impervious to drugs. Yet, how well these new tests fare in gauging risk of actual drug failure and patient death has remained unclear.

4 Aug 2017

Researchers develop potential stem cell treatment for several lung conditions

A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis -- often-fatal conditions that affect tens of millions of Americans.

3 Aug 2017

Study finds current annual TB screening in North America to be costly with limited health benefits

Tuberculosis (TB) is a recognized hazard for healthcare workers, but the annual screening strategy currently in place in Canada and the United States is costly with very limited health benefits and should be reconsidered, according to a new study led by a team from the Research Institute of the McGill University Health Centre.

31 Jul 2017

Researchers unravel how acidic conditions favor protein misfolding in deadly diseases

Using an array of modern biochemical and structural biology techniques, researchers from Boston University School of Medicine have begun to unravel the mystery of how acidity influences a small protein called serum amyloid A (SAA).

28 Jul 2017

New approach may improve translation of immunological research findings

Mouse models have advanced our understanding of immune function and disease in many ways but they have failed to account for the natural diversity in human immune responses.

27 Jul 2017

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million (3.9) with chronic hepatitis C infection.

26 Jul 2017

New report says completing a course of antibiotics even after symptoms abate is overrated

Antibiotics are a boon to mankind and as more and more microorganisms are developing a resistance to these drugs, researchers are delving deeper into the mechanisms of this resistance. It is a commonly held view that once begun, a course of antibiotics should be completed to prevent the emergence of resistance among the microbes.

26 Jul 2017

Cocktail of drugs for HIV patients with advanced immunosuppression reduced deaths by 27%, study shows

A study published in the New England Journal of Medicine on 20th July 2017 suggests that a cocktail of drugs, if provided at the beginning of the HIV therapy, can save over 10,000 lives per year. HIV, which is often diagnosed late, leaves people vulnerable to other diseases by ravaging the immune system.

25 Jul 2017

Tuberculosis News and Research

Latest Tuberculosis News and Research

Disease diagnostic tools win top honors in DEBUT challenge

Living near newly built roads in Ethiopia linked to higher rates of infant mortality

Understanding the rise in NTM infections

South Texas fights tuberculosis one blood test at a time

New way of screening compounds may help speed up drug development

Molecular tests that detect drug-resistant TB may become faster alternative to traditional testing

Researchers develop potential stem cell treatment for several lung conditions

Study finds current annual TB screening in North America to be costly with limited health benefits

Researchers unravel how acidic conditions favor protein misfolding in deadly diseases

New approach may improve translation of immunological research findings

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

New report says completing a course of antibiotics even after symptoms abate is overrated

Cocktail of drugs for HIV patients with advanced immunosuppression reduced deaths by 27%, study shows

Genetic variation linked to greater tuberculosis susceptibility

WHO alerts countries to increasing trend of HIV drug resistance

Researchers discover gene mutations that worsen respiratory infections among children

MSU professor uses lessons from ancient skeletal remains to understand spread of modern diseases

LSTM awarded £11 million by NIHR to establish new research unit and groups

Antimicrobial peptide packaged in silicon nanoparticle could combat drug-resistant bacteria

New Cornell discovery could lead to effective treatment for tuberculosis

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in